Galectin Therapeutics Files 8-K
Ticker: GALT · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1133416
| Field | Detail |
|---|---|
| Company | Galectin Therapeutics INC (GALT) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
GALECTIN THERAPEUTICS INC. filed an 8-K on 6/16/2025 for Reg FD and exhibits.
AI Summary
Galectin Therapeutics Inc. filed an 8-K on June 16, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Pro Pharmaceuticals Inc., is incorporated in Nevada and headquartered in Norcross, Georgia.
Why It Matters
This filing indicates routine corporate reporting and potential updates on financial status or disclosures relevant to investors.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for corporate disclosures and does not appear to contain significant new risks.
Key Numbers
- 001-31791 — SEC File Number (Identifies the company's filing history with the SEC.)
- 04-3562325 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- GALECTIN THERAPEUTICS INC. (company) — Registrant
- PRO PHARMACEUTICALS INC (company) — Former company name
- June 16, 2025 (date) — Date of report
- Norcross, GA (location) — Principal executive office location
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the report filed?
The report was filed on June 16, 2025.
What is the company's former name?
The company's former name was PRO PHARMACEUTICALS INC.
Where is Galectin Therapeutics Inc. headquartered?
The company is headquartered at 4960 PEACHTREE INDUSTRIAL BOULEVARD, STE 240, NORCROSS, GA 30071.
In which state is Galectin Therapeutics Inc. incorporated?
Galectin Therapeutics Inc. is incorporated in Nevada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding GALECTIN THERAPEUTICS INC (GALT).